Prescription drug · ANDA
Acarbose NDC 23155-149
Acarbose 100 mg/1 · Tablet · Oral · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 23155-149-01 | 23155014901 | 100 TABLET in 1 BOTTLE (23155-149-01)Marketed from Apr 16, 2021 | |
| 23155-149-05 | 23155014905 | 500 TABLET in 1 BOTTLE (23155-149-05)Marketed from Apr 16, 2021 | |
| 23155-149-10 | 23155014910 | 1000 TABLET in 1 BOTTLE (23155-149-10)Marketed from Apr 16, 2021 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Acarbose
- Generic name (nonproprietary)
- acarbose
- Active ingredients
- Acarbose — 100 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 202271
- Marketing start
- Listing expires
- Other FDA classes
- alpha Glucosidase Inhibitors (Mechanism)
- Identifiers
- Product ID 23155-149_dc1b5c0e-cd6b-482e-9388-e9183ca499e9SPL ID dc1b5c0e-cd6b-482e-9388-e9183ca499e9SPL set ID 29939129-7d09-4c22-bf3e-491a8a97f4c4RxCUI 199149, 199150, 200132UNII T58MSI464G
- Pharmacologic class
- alpha-Glucosidase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N423155014901followed by a unit qualifier and the quantityPackage 23155-0149-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Acarbose tablets, USP are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 202271
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Acarbose | Acarbose 25 mg/1 | TabletOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-147 |
| Acarbose | Acarbose 50 mg/1 | TabletOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-148 |
| Acarbose | Acarbose 50 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-9725 |
| Acarbose | Acarbose 25 mg/1 | TabletOral | Chartwell RX, LLC | 62135-453 |
| Acarbose | Acarbose 50 mg/1 | TabletOral | Chartwell RX, LLC | 62135-454 |
| Acarbose | Acarbose 100 mg/1 | TabletOral | Chartwell RX, LLC | 62135-455 |